ReviewThe European journal of neuroscience2025
Psychoneural reduction revised: The case of suicidality in bipolar disorder.
Review in The European journal of neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Are Adults With Bipolar Disorder at Increased Cardiovascular Risk due to Their Physical, Biochemical, and Physiological Profiles? The FINEXT-BD Study.Brain and behavior · 2025Article
- Psychoneural reduction revised: The case of suicidality in bipolar disorder.The European journal of neuroscience · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
This paper uses suicidality in bipolar disorder (BD) to illustrate that multidimensional frameworks account for complex phenomena with cognitive, psychological, socioenvironmental and physiological components better than their reductionist counterparts. We challenge level-based reductionist models that regard a particular dimension as fundamental. To comprehensively understand complex psychiatric phenomena, multidimensional models that acknowledge the heterogeneity of aetiological factors, rather than homogenising them under a single dimension, must be utilised. Multidimensional models allow a better understanding of the individual context under which a psychiatric phenomenon arises, and the interrelationships between its different aetiological dimensions. Suicidality in BD is used as a case study because it particularly highlights the interplay between biological, psychological, sociocultural and experiential factors. The multidimensional nature of suicidality is reflected by the heterogeneous strategies by which it is managed. Although similar to suicidality in other contexts, in BD suicidality has distinctive structural characteristics that emphasise its multidimensionality. Consequently, investigating suicidality in BD yields claims generalisable to suicidality as a whole alongside novel insights on BD-specific features. For instance, suicidality in BD has physiological causal factors, e.g., genetic predisposition and aggravation by symptomatic periods. However, its other features underscore the causal roles of cognitions. In persons with BD, suicidality can persist beyond depression and is sometimes experienced during mania, possibly due to suicidal ideation persisting beyond symptomatic periods. This indicates the need to account for cognitive or psychological causal factors. Models of suicidality in BD typically adopt a non-level-based, non-reductionist approach, reflected in the diverse clinical strategies for managing suicidality in BD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.